Accelerated Enrollment Solutions (AES), a business unit of Pharmaceutical Product Development, LLC (PPD), has acquired the clinical research site business of Bioclinica, expanding AES’ global footprint and position in patient access and site conduct. AES services now extend across five continents, 20 countries, over 180 research sites and more than 100 million households.   The acquisition extends AES’ reach into China, Latin America and Western Europe, augmenting its presence in North A...